BlackRock, Inc. - 31 Mar 2025 SCHEDULE 13G/A Report for Allogene Therapeutics, Inc Common Stock (ALLO)

Filing Manager: BlackRock, Inc.
Reporting Manager: BlackRock, Inc.
Security: Allogene Therapeutics, Inc Common Stock
Symbol: ALLO
Shares outstanding: 216,039,226 shares
Disclosed Ownership: 11,450,079 shares
Ownership: 5.3%
Form type: SCHEDULE 13G/A
Filing time: 17 Apr 2025, 09:35:33 UTC
Date of event: 31 Mar 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
BlackRock, Inc.	5.3%	11,450,079	11,294,846	0	Spencer Fleming	Managing Director